Dr. Ann Simon has worked in finance, particulary in the life sciences and technology sectors, since 1985. She is currently a non-executive director of Scientific Digital Imaging (where she chairs the audit committee) and Lumacron and is providing consultancy in the areas of finance, strategic planning, enablement and funding to development-stage life sciences companies including Peptinnovate and OBS Medical.
Over the past 15 years she has held roles including chairman of OBS Medical and Chief Financial Officer of Pyreos, mLED, Sphere Medical Holding, Genosis, Mirada Solutions, NextGen Sciences, e-San and Bioglan Pharma. Prior to that she undertook corporate finance advisory work at Cazenove & Co. over more than a decade for clients ranging from start-ups to FTSE100 companies. She has managed IPOs (London full list and AIM), corporate acquisitions and trade sales and fund raisings in the public and private markets.
Ann was on the FSA’s Financial Information Theme Team from 2002 to 2003. She originally qualified as a physicist and completed 10 years of postgraduate physics at the Cavendish Laboratory. Cambridge including periods spent in Germany, France and the USA.